Monitorización de niveles de sirolimus: ¿cómo afecta el inmunoensayo utilizado?
Monitoring sirolimus levels: How does it affect the immunoassay used?
Leído
24013
Vecesse ha leído el artículo
3464
Total PDF
20549
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 124 | 31 | 155 |
| 2025 9 | 163 | 33 | 196 |
| 2025 8 | 106 | 40 | 146 |
| 2025 7 | 140 | 16 | 156 |
| 2025 6 | 196 | 89 | 285 |
| 2025 5 | 170 | 38 | 208 |
| 2025 4 | 181 | 24 | 205 |
| 2025 3 | 219 | 52 | 271 |
| 2025 2 | 244 | 28 | 272 |
| 2025 1 | 177 | 27 | 204 |
| 2024 12 | 167 | 27 | 194 |
| 2024 11 | 210 | 45 | 255 |
| 2024 10 | 183 | 38 | 221 |
| 2024 9 | 194 | 30 | 224 |
| 2024 8 | 152 | 57 | 209 |
| 2024 7 | 155 | 24 | 179 |
| 2024 6 | 130 | 47 | 177 |
| 2024 5 | 148 | 31 | 179 |
| 2024 4 | 142 | 31 | 173 |
| 2024 3 | 132 | 21 | 153 |
| 2024 2 | 105 | 37 | 142 |
| 2024 1 | 154 | 28 | 182 |
| 2023 12 | 132 | 25 | 157 |
| 2023 11 | 142 | 30 | 172 |
| 2023 10 | 125 | 34 | 159 |
| 2023 9 | 168 | 31 | 199 |
| 2023 8 | 144 | 17 | 161 |
| 2023 7 | 122 | 23 | 145 |
| 2023 6 | 141 | 34 | 175 |
| 2023 5 | 151 | 37 | 188 |
| 2023 4 | 98 | 16 | 114 |
| 2023 3 | 129 | 33 | 162 |
| 2023 2 | 120 | 30 | 150 |
| 2022 1 | 125 | 31 | 156 |
| 2022 12 | 127 | 41 | 168 |
| 2022 11 | 139 | 45 | 184 |
| 2022 10 | 137 | 47 | 184 |
| 2022 9 | 96 | 52 | 148 |
| 2022 8 | 106 | 63 | 169 |
| 2022 7 | 121 | 58 | 179 |
| 2022 6 | 90 | 48 | 138 |
| 2022 5 | 87 | 43 | 130 |
| 2022 4 | 95 | 54 | 149 |
| 2022 3 | 97 | 71 | 168 |
| 2022 2 | 107 | 54 | 161 |
| 2021 1 | 87 | 43 | 130 |
| 2021 12 | 96 | 42 | 138 |
| 2021 11 | 129 | 49 | 178 |
| 2021 10 | 139 | 56 | 195 |
| 2021 9 | 278 | 39 | 317 |
| 2021 8 | 127 | 39 | 166 |
| 2021 7 | 101 | 53 | 154 |
| 2021 6 | 119 | 32 | 151 |
| 2021 5 | 106 | 43 | 149 |
| 2021 4 | 206 | 82 | 288 |
| 2021 3 | 179 | 36 | 215 |
| 2021 2 | 118 | 37 | 155 |
| 2020 1 | 92 | 29 | 121 |
| 2020 12 | 76 | 14 | 90 |
| 2020 11 | 90 | 12 | 102 |
| 2020 10 | 90 | 18 | 108 |
| 2020 9 | 104 | 14 | 118 |
| 2020 8 | 80 | 15 | 95 |
| 2020 7 | 79 | 10 | 89 |
| 2020 6 | 79 | 18 | 97 |
| 2020 5 | 75 | 21 | 96 |
| 2020 4 | 101 | 19 | 120 |
| 2020 3 | 115 | 23 | 138 |
| 2020 2 | 115 | 26 | 141 |
| 2020 1 | 116 | 19 | 135 |
| 2019 12 | 85 | 23 | 108 |
| 2019 11 | 115 | 19 | 134 |
| 2019 10 | 123 | 338 | 461 |
| 2019 9 | 167 | 18 | 185 |
| 2019 8 | 118 | 15 | 133 |
| 2019 7 | 145 | 25 | 170 |
| 2019 6 | 137 | 25 | 162 |
| 2019 5 | 165 | 9 | 174 |
| 2019 4 | 209 | 34 | 243 |
| 2019 3 | 85 | 24 | 109 |
| 2019 2 | 109 | 25 | 134 |
| 2019 1 | 107 | 21 | 128 |
| 2018 12 | 325 | 44 | 369 |
| 2018 11 | 342 | 15 | 357 |
| 2018 10 | 390 | 12 | 402 |
| 2018 9 | 374 | 18 | 392 |
| 2018 8 | 208 | 19 | 227 |
| 2018 7 | 161 | 10 | 171 |
| 2018 6 | 147 | 17 | 164 |
| 2018 5 | 135 | 12 | 147 |
| 2018 4 | 131 | 14 | 145 |
| 2018 3 | 128 | 17 | 145 |
| 2018 2 | 150 | 5 | 155 |
| 2018 1 | 156 | 8 | 164 |
| 2017 12 | 120 | 10 | 130 |
| 2017 11 | 142 | 12 | 154 |
| 2017 10 | 91 | 4 | 95 |
| 2017 9 | 100 | 14 | 114 |
| 2017 8 | 136 | 20 | 156 |
| 2017 7 | 138 | 7 | 145 |
| 2017 6 | 122 | 18 | 140 |
| 2017 5 | 103 | 5 | 108 |
| 2017 4 | 78 | 12 | 90 |
| 2017 3 | 76 | 7 | 83 |
| 2017 2 | 296 | 10 | 306 |
| 2016 1 | 104 | 8 | 112 |
| 2016 12 | 137 | 12 | 149 |
| 2016 11 | 236 | 14 | 250 |
| 2016 10 | 193 | 22 | 215 |
| 2016 9 | 305 | 2 | 307 |
| 2016 8 | 329 | 14 | 343 |
| 2016 7 | 288 | 6 | 294 |
| 2016 6 | 190 | 0 | 190 |
| 2016 5 | 181 | 0 | 181 |
| 2016 4 | 124 | 0 | 124 |
| 2016 3 | 130 | 0 | 130 |
| 2016 2 | 159 | 0 | 159 |
| 2015 1 | 135 | 0 | 135 |
| 2015 12 | 169 | 0 | 169 |
| 2015 11 | 117 | 0 | 117 |
| 2015 10 | 126 | 0 | 126 |
| 2015 9 | 95 | 0 | 95 |
| 2015 8 | 114 | 0 | 114 |
| 2015 7 | 100 | 0 | 100 |
| 2015 6 | 47 | 0 | 47 |
| 2015 5 | 99 | 0 | 99 |
| 2015 4 | 42 | 0 | 42 |
| 2015 2 | 2227 | 0 | 2227 |
Mostrar todo
